The German life science and medtech private equity firm SHS Capital has made a EUR 10 million investment in Simulands, a Swiss manufacturer of simulation devices for medical training of cardiovascular interventions. The investment aims to accelerate the commercialization of this early-stage company and to help it revolutionize cardiovascular education and training. Simulands plans to […]
Vifor Pharma Group closed its divestment transaction regarding its finished drug product manufacturing business with facilities in Fribourg, Ettingen (both in Switzerland) and Lisbon (Portugal) to CordenPharma, a full-service Contract Development & Manufacturing Organisation (CDMO)
The team was led by Stefan Kohler (IP / Life Sciences - pictured) and Christoph Niederer (Tax).
The VISCHER team, led by partner Robert Bernet (Corporate / M & A - pictured) includes Peter Kühn (Counsel, Corporate / M & A), Florian Kambor (Junior Associate, Corporate / M & A) and Christian Wyss (Partner, IP).
The team was led by partner Emanuel Dettwiler (Corporate/M&A - pictured) and comprised senior associate Sophie Holdt (Corporate/M&A).
Freshfields Bruckhaus Deringer acted as legal advisor to Novartis.
VISCHER advises Polyneuron with a team led by Matthias Staehelin (Partner - pictured) with Moritz Jäggy (Managing Associate), both Corporate.
Montefarmaco, a privately held Italian pharmaceutical company, has acquired Jordan Tech
